论文部分内容阅读
目的探讨盐酸氨溴索治疗新生儿感染性肺炎的临床疗效。方法选取2014年12月—2015年3月梅河口市黑山头镇卫生院收诊的100例感染性肺炎患儿,将其随机分为对照组(n=50)与试验组(n=50)。对照组予以常规治疗,试验组在对照组基础上增加盐酸氨溴索治疗。比较两组患儿退热时间、啰音消失时间、吸痰次数、住院时间、临床疗效及不良反应发生率。结果试验组退热时间、啰音消失时间、住院时间短于对照组,吸痰次数少于对照组,总有效率高于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论盐酸氨溴索治疗新生儿感染性肺炎的疗效确切,且不良反应少。
Objective To investigate the clinical efficacy of ambroxol hydrochloride in the treatment of neonatal pneumonia. Methods A total of 100 children with infectious pneumonia were enrolled from December 2014 to March 2015 in Heishantou Hospital of Meihekou City. They were randomly divided into control group (n = 50) and experimental group (n = 50) . The control group was given routine treatment, and the experimental group was given ambroxol hydrochloride on the basis of the control group. The two groups of children with antipyretic time, rales disappear time, suction number, hospital stay, clinical efficacy and adverse reactions. Results In the experimental group, the time of fever relief, the disappearance of rales and hospital stay were shorter than those of the control group, the number of sputum aspiration was less than that of the control group, the total effective rate was higher than that of the control group, the incidence of adverse reactions was lower than that of the control group, the difference was statistically significant P <0.05). Conclusion Ambroxol Hydrochloride for the treatment of neonatal pneumonia is effective and has few adverse reactions.